Abstract
The abbreviated impactor measurement (AIM) and efficient data analysis (EDA) concepts for the in vitro assessment of orally inhaled drug products (OIPs), comprising pressurized metered-dose inhalers (MDIs), soft mist inhalers (SMIs), dry powder inhalers (DPIs), and nebulizing systems, are the topics covered by this book. The chief aims are to provide to potential adoptees of these new methods answers to “how to” questions, as well as to those charged with regulatory oversight assurance that both concepts are fully founded on valid scientific principles. A chapter reviewing the cascade impaction method applied to the assessment of OIPs is also included in order to provide the reader with the necessary background material before exploring the extensions to current methodologies associated with AIM and EDA. Both concepts are related, but do not necessarily need to be applied together, nor is AIM an all-purpose replacement for OIP aerodynamic particle size distribution (APSD) measurements by full-resolution cascade impactor (CI).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonam M, Christopher D, Cipolla D, Donovan B, Goodwin D, Holmes S, Lyapustina S, Mitchell J, Nichols S, Petterson G, Quale C, Rao N, Singh D, Tougas T, Van Oort M, Walther B, Wyka B (2008) Minimizing variability of cascade impaction measurements in inhalers and nebulizers. AAPS PharmSciTech 9(2):404–413
Mitchell JP, Nagel MW (2003) Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med 16(4):341–377
Rudolph G, Köbrich R, Stahlhofen W (1990) Modeling and algebraic formulation of regional aerosol deposition in man. J Aerosol Sci 21(S1):S403–S406
Heyder J, Svartengren MU (2002) Basic principles of particle behavior in the human respiratory tract. In: Bisgaard H, O’Callaghan C, Smaldone GC (eds) Drug delivery to the lung. Dekker, New York, NY
Christopher D, Curry P, Doub B, Furnkranz K, Lavery M, Lin K, Lyapustina S, Mitchell J, Rogers B, Strickland H, Tougas T, Tsong Y, Wyka B (2003) Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree. J Aerosol Med 16:235–247
Van Oort M, Roberts W (1996) Variable stage-variable volume strategy for cascade impaction. In: Dalby RN, Byron PR, Farr EJ (eds) Respiratory drug delivery-V. Interpharm Press, Buffalo Grove, IL, pp 418–421
Dunbar C, Mitchell JP (2005) Analysis of cascade impactor mass distributions. J Aerosol Med 18(4):439–451
European Directorate for the Quality of Medicines and Healthcare (EDQM) (2012) Preparations for inhalation: aerodynamic assessment of fine particles, Chapter 2.9.18. In: European Pharmacopeia, 7th edn. Strasbourg, France
United States Pharmacopeial Convention (USP) (2012) Aerosols, metered-dose inhalers, and dry powder inhalers USP35-NF30, Chapter 601. Rockville, MD
Mitchell JP, Dolovich MB (2012) Clinically relevant test methods to establish in vitro equivalence for spacers and valved holding chambers used with pressurized metered dose inhalers (pMDIs). J Aerosol Med Pulm Deliv 25(4):217–242
Tougas TP, Christopher D, Mitchell JP, Strickland H, Wyka B, Van Oort M, Lyapustina S (2009) Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs). AAPS PharmSciTech 10(4):1276–1285
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tougas, T.P., Mitchell, J.P., Morgan, B., Strickland, H. (2013). Introduction. In: Tougas, T., Mitchell, J., Lyapustina, S. (eds) Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-6296-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6296-5_1
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-6295-8
Online ISBN: 978-1-4614-6296-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)